A modified human ELISPOT assay to detect specific responses to primary tumor cell targets
<p>Abstract</p> <p>Background</p> <p>The desired outcome of cancer vaccination is to induce a potent T cell response which can specifically recognize and eliminate autologous tumor cells <it>in vivo</it>. Accordingly, immunological assays that demonstrate recognition of native tumor cells (tumor-spe...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2004-03-01
|
| Edice: | Journal of Translational Medicine |
| On-line přístup: | http://www.translational-medicine.com/content/2/1/9 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|